Novara Mark David

Track

Insider profile

Novara Mark David's trades of Tandem Diabetes Care, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
126.51
Quantity 46,400
Value US$3,907,913
Transaction date
Proposed sale
Price
250.89
Quantity 11,687
Value US$4,059,953
Transaction date
Proposed sale
Price
274.82
Quantity 7,719
Value US$2,520,007
Transaction date
Proposed sale
Price
13.53
Quantity 266
Value US$3,599
Transaction date
Proposed sale
Price
21.91
Quantity 187
Value US$4,097
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-17 2026-09-17
PrS Proposed sale
46,400
126.51
US$3,907,913 		46,400 126.51 US$3,907,913
2026-08-18 2026-08-18
PrS Proposed sale
11,687
250.89
US$4,059,953 		11,687 250.89 US$4,059,953
2026-06-17 2026-06-17
PrS Proposed sale
7,719
274.82
US$2,520,007 		7,719 274.82 US$2,520,007
2026-05-19 2026-05-19
PrS Proposed sale
266
13.53
US$3,599 		266 13.53 US$3,599
2026-03-18 2026-03-17
PlS Planned sale
187 -0.5%
23.05
US$4,310 		187 -0.5% 23.05 US$4,310
2026-03-17 2026-03-17
PrS Proposed sale
187
21.91
US$4,097 		187 21.91 US$4,097
2026-03-09 2026-03-05
PlS Planned sale
2 -0.0%
22.81
US$46 		2 -0.0% 22.81 US$46
2026-03-05 2026-03-05
PrS Proposed sale
2
23.41
US$47 		2 23.41 US$47
2024-11-19 2024-11-15
PP Planned purchase
532 +inf%
23.24
US$12,364 		532 +inf% 23.24 US$12,364